How many stocks are there of Calyxt?
The current number of stocks of Calyxt is 919,950 undefined.
Calyxt Stocks 2025
Calyxt Stocks
919,950
Ticker
CLXT
ISIN
US13173L1070
WKN
A2DU9F
In 2025, Calyxt had 919,950 outstanding stocks, a 0% change from the 919,950 stocks in the previous year.
The Calyxt Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2028e | 0.92 |
| 2027e | 0.92 |
| 2026e | 0.92 |
| 2025e | 0.92 |
| 2024e | 0.92 |
| 2023e | 0.92 |
| 2022 | 0.92 |
| 2021 | 0.75 |
| 2020 | 0.68 |
| 2019 | 32.81 |
| 2018 | 30.68 |
| 2017 | 23.15 |
| 2016 | 25.66 |
| 2015 | 25.66 |
Calyxt shares outstanding US13173L1070 · A2DU9F
The number of shares was Calyxt in 2024 — This indicates how many shares 919,950 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Calyxt earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Calyxt's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Calyxt’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Calyxt's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2015 | 25.66 M Aktien |
| 2016 | 25.66 M Aktien |
| 2017 | 23.15 M Aktien |
| 2018 | 30.68 M Aktien |
| 2019 | 32.81 M Aktien |
| 2020 | 677,650 Aktien |
| 2021 | 749,520 Aktien |
| 2022 | 919,950 Aktien |
| 2023e | 919,950 Aktien |
| 2024e | 919,950 Aktien |
| 2025e | 919,950 Aktien |
| 2026e | 919,950 Aktien |
| 2027e | 919,950 Aktien |
| 2028e | 919,950 Aktien |
Calyxt Aktienanalyse
What does Calyxt do?
Calyxt Inc. is a US company specializing in the development and marketing of genetically modified plants. The company was founded in Minnesota in 2010 with the aim of producing high-quality, healthy, and environmentally friendly products that meet the requirements of modern and sustainable nutrition. History The history of Calyxt Inc. began with the idea of revolutionizing the cultivation of crops. The company was founded by Cellectis SA, which already had experience in the field of molecular biology. Calyxt developed technological processes for rapid genetic manipulation of plants that had the potential to change the entire agricultural industry. Business Model Calyxt follows an "end-to-end" business model, meaning the company offers products and services along the entire value chain. This ranges from the development of new plants through genetic modifications to the distribution and marketing of the end products. Divisions Calyxt specializes in the development of plant varieties optimized through genetic manipulation. The company has various divisions that focus on specific plant species, including: - Soybeans: Calyxt has developed a new variety of soybeans that contains a higher proportion of oleic acid, which improves the durability and quality of the beans. - Wheat: The company has also developed a variety of wheat that is low in gluten. This allows people with celiac disease or other reasons to avoid gluten to consume this variety. - Potatoes: Calyxt has developed a new variety of potatoes that contains less acrylamide than other varieties. Acrylamide is formed during the production of fries and chips and is suspected to cause cancer. Products Calyxt offers various products made from the plants they have developed, including: - Soybean oil: Calyxt soybean oil contains a higher proportion of healthy omega-3 fatty acids compared to conventional soybean oil. - Flour: Calyxt wheat flour is low in gluten and can be consumed by people with celiac disease or other reasons to avoid gluten. - Fries and chips: Calyxt potatoes contain less acrylamide than conventional potatoes, resulting in the formation of fewer harmful substances during the preparation of fries and chips. Conclusion Calyxt Inc. is an American company that develops genetically modified plants and connects them with customers, mainly in the food sector. The company aims to produce healthy, environmentally friendly, and high-quality products that meet the requirements of modern and sustainable nutrition. Various plant species are genetically modified to improve the durability and quality of the products while minimizing health risks. Calyxt Inc. offers various products made from the plants they have developed, with a focus on the production of fries and chips, as well as the distribution of soybean oil and low-gluten wheat flour. Calyxt has the potential to change modern agriculture through its innovative and sustainable products. Calyxt ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Calyxt's Shares Outstanding
Calyxt's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Calyxt’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Calyxt’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Calyxt’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Calyxt stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Calyxt are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Calyxt evolved in recent years?
The number of shares of Calyxt has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Calyxt as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Calyxt?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Calyxt pay?
Over the past 12 months, Calyxt paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Calyxt is expected to pay a dividend of 0 USD.
What is the dividend yield of Calyxt?
The current dividend yield of Calyxt is .
When does Calyxt pay dividends?
Calyxt pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Calyxt?
Calyxt paid dividends every year for the past 0 years.
What is the dividend of Calyxt?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Calyxt located?
Calyxt is assigned to the 'Health' sector.
Wann musste ich die Aktien von Calyxt kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Calyxt from 1/17/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/17/2025.
When did Calyxt pay the last dividend?
The last dividend was paid out on 1/17/2025.
What was the dividend of Calyxt in the year 2024?
In the year 2024, Calyxt distributed 0 USD as dividends.
In which currency does Calyxt pay out the dividend?
The dividends of Calyxt are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Calyxt
Our stock analysis for Calyxt Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Calyxt Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
